UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

Haematologica (Roma), 2010-07, Vol.95 (7), p.1191-1197

2010

Volltextzugriff (PDF)

Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia

Blood, 2012-08, Vol.120 (6), p.1282-1289

2012

Volltextzugriff (PDF)

Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition

Haematologica (Roma), 2017-12, Vol.102 (12), p.e499

2017

Volltextzugriff (PDF)

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

Transfusion (Philadelphia, Pa.), 2011-03, Vol.51 (3), p.591-599

2011

Volltextzugriff (PDF)

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Blood, 2022-09, Vol.140 (11), p.1200-1228

2022

Volltextzugriff (PDF)

Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma

Haematologica (Roma), 2015-07, Vol.100 (7), p.e285

2015

Volltextzugriff (PDF)

Cell-based immunotherapy approaches for multiple myeloma

British journal of cancer, 2019-01, Vol.120 (1), p.38-44

2019

Volltextzugriff (PDF)

Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1mut)

Blood, 2013-08, Vol.122 (6), p.1087-1088

2013

Volltextzugriff (PDF)

RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

Blood, 2008-02, Vol.111 (3), p.1357-1365

2008

Volltextzugriff (PDF)

Retrospective study on pomalidomide‐ PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma

European journal of haematology, 2024-06

2024

Volltextzugriff (PDF)

Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches

Blood, 2006-12, Vol.108 (13), p.4109-4117

2006

Volltextzugriff (PDF)

Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells

British journal of haematology, 2009-01, Vol.144 (2), p.195-205

2009

Volltextzugriff (PDF)

Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma

Transfusion (Philadelphia, Pa.), 2015-02, Vol.55 (2), p.275-283

2015

Volltextzugriff (PDF)

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

The Lancet. Haematology, 2022-11, Vol.9 (11), p.e810-e821

2022

Volltextzugriff (PDF)

Identification and characterization of epitopes of the receptor for hyaluronic acid–mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2–positive patients with acute myeloid leukemia

Blood, 2005-08, Vol.106 (3), p.938-945

2005

Volltextzugriff (PDF)

Local Radiation Therapy Before and During Induction Delays Stem Cell Mobilization and Collection in Multiple Myeloma Patients

Transplantation and cellular therapy, 2021-10, Vol.27 (10), p.876.e1-876.e11

2021

Volltextzugriff (PDF)

Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myeloma

Journal of clinical apheresis, 2014-12, Vol.29 (6), p.299-304

2014

Volltextzugriff (PDF)

Expression of human leucocyte antigens and co‐stimulatory molecules on blasts of patients with acute myeloid leukaemia

British journal of haematology, 2003-03, Vol.120 (6), p.1000-1008

2003

Volltextzugriff (PDF)

Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group

British journal of haematology, 2001-08, Vol.114 (2), p.342-348

2001

Volltextzugriff (PDF)

Reduced‐intensity conditioning followed by T‐cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse

British journal of haematology, 2007-01, Vol.136 (1), p.127-130

2007

Volltextzugriff (PDF)

CD34+ cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients

British journal of haematology, 2004-08, Vol.126 (4), p.527-535

2004

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

KollektionSpringer Nature - Complete Springer Journals

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(7)
British Journal Of Haematology
(5)
Haematologica
(3)
Transfusion
(2)
British Journal Of Cancer
(1)
European Journal Of Haematology
(1)
Journal Of Clinical Apheresis
(1)
The Lancet. Haematology
(1)
Transplantation And Cellular Therapy
(1)

4 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia

Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma

Cell-based immunotherapy approaches for multiple myeloma

Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1mut)

The EUROclass trial: defining subgroups in common variable immunodeficiency

RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

Retrospective study on pomalidomide‐ PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma

Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches

Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells

Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

Identification and characterization of epitopes of the receptor for hyaluronic acid–mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2–positive patients with acute myeloid leukemia

Local Radiation Therapy Before and During Induction Delays Stem Cell Mobilization and Collection in Multiple Myeloma Patients

Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myeloma

Expression of human leucocyte antigens and co‐stimulatory molecules on blasts of patients with acute myeloid leukaemia

Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group

Reduced‐intensity conditioning followed by T‐cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse

CD34+ cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients

Aktive Filter

Suchergebnisse filtern